Myosin modulators move forward with FDA approval of mavacamten.

Publication Type Academic Article
Authors Chin A, Day S
Journal Nat Cardiovasc Res
Volume 1
Issue 7
Pagination 595-596
Date Published 07/01/2022
ISSN 2731-0590
DOI 10.1038/s44161-022-00093-x
PubMed ID 39196240
Back to Top